The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / December / Rare Disease Reanalysis Ended Our 5Year Wait
Biochemistry and molecular biology Genetics and epigenetics Clinical care Voices in the Community Research and Innovations

Rare Disease Reanalysis Ended Our 5-Year Wait

In conversation with the clinician who developed the proactive exome reanalysis approach, and the mother whose child benefited from it

12/23/2025 Interview 4 min read
  • Full Article
  • Summary
  • Top Institutions

Share

Top Institutions in Genetics

The ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.

  • #1

    Broad Institute of MIT and Harvard

    Cambridge, Massachusetts

    Recognized leader in rare disease genomics with multiple NIH-funded programs and clinical trials.

    Key Differentiators

    • Genetics
    • Genomics
  • #2

    Baylor College of Medicine

    Houston, Texas

    Strong infrastructure for clinical reanalysis and multiple active rare-disease trials.

    Key Differentiators

    • Genetics
    • Pediatrics
  • #3

    Cornell University

    Ithaca, New York

    Pioneered HiFi sequencing technology contributing to advancements in genomics.

    Key Differentiators

    • Genetics
  • #4

    Genomics England

    London, England

    Leader in generating evidence for new therapy pathways for ultra-rare diseases.

    Key Differentiators

    • Genomics
    • Rare Diseases
  • #5

    The Acute Care Genomics program

    Australia, N/A

    Provided ultra-rapid genomic diagnosis for critically ill children.

    Key Differentiators

    • Genetics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.